Fundz

Enveric Biosciences Announces Closing Of Magicmed Industries Acquisition

PUBLIC · ENVBSep 18, 2021

Acquiring Company

Enveric Biosciences

CambridgeBiotechnologyHealthcareHealth CareScience And Engineering

Description

Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-centric biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer patients, today announced the closing of its acquisition of MagicMed Industries Inc. ("MagicMed"), a privately-held biotechnology company focused on creating a library of novel derivative psychedelic molecules such as psilocybin, N,N-dimethyltryptamine (DMT) and other molecular derivatives with applications across multiple indications, in an all-stock transaction.

Who to call at Enveric Biosciences, and when

When Enveric Biosciences changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Enveric Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Enveric Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Enveric Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Enveric Biosciences

Location

Cambridge, Massachusetts, United States

About

Enveric Biosciences (NASDAQ: ENVB) is an innovative biotechnology company developing a next-generation mental health and oncology treatment clinical discovery platform, leveraging psychedelic-derived molecules for the mind and synthetic cannabinoids for the body. Enveric's robust pipeline supports drug development from the clinic to commercialization for millions of patients in need around the world suffering from conditions that include cancer-related distress, PTSD and more.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Enveric Biosciences makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Kevin
Likely contact at this company
••••••••@••••••••

See Kevin's verified email →

Sheetal
Senior decision-maker at this company
••••••••@••••••••

See Sheetal's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Enveric Biosciences's next move

Learn about Strategic plan

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.